Clinical Trials Directory

Trials / Unknown

UnknownNCT03108677

Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma

A Pilot Study of Circulating Exosome RNA as Diagnostic and Prognostic Markers in Lung Metastases of Primary High-Grade Osteosarcoma

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
12 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn whether the profile of RNA from circulating exosomes can be used as a biomarker for lung metastases of primary high-grade osteosarcoma. Circulating exosomes plays roles in metastases in many kinds of cancer including osteosarcoma. By RNA profiling researchers may find lung metastases earlier than conventional work-up and predict the oncological outcomes.

Detailed description

Investigators have performed a 4 patients pilot study under the oversight of hospital's ethics committee, and investigator found that the levels and mutations of circulating exosome RNA from patients with or without lung metastasis have significant differences. Then investigators wish to register this study to do a further research, in order to reveal the roles of circulating exosome RNA in metastases of osteosarcoma.

Conditions

Interventions

TypeNameDescription
OTHERBlood samples15 ml peripheral blood

Timeline

Start date
2017-05-01
Primary completion
2023-09-19
Completion
2023-12-30
First posted
2017-04-11
Last updated
2023-10-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03108677. Inclusion in this directory is not an endorsement.